Defining the Scope of Exposome Studies and Research Needs from a Multidisciplinary PerspectivePei Zhang, Craig E. Wheelock, Mengna Huang et al.|Environmental Science & Technology Letters|2021Cited by 153
LBA12 Efficacy and safety of IBI351 (GFH925), a selective KRASG12C inhibitor, monotherapy in patients (pts) with advanced non-small cell lung cancer (NSCLC): Initial results from a registrational phase II studyQing Zhou, Yi‐Long Wu, Xue Meng et al.|Annals of Oncology|2023Cited by 10